Research and experimental development on natural sciences and engineering
NYKODE THERAPEUTICS ASA
Revenue 2024
NOK 9.2m
Operating profit
NOK −45.7m
Equity
NOK 140.1m
Incorporated
2006
Employees
46
Share capital
NOK 3.3m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 9.2m | |
| Total operating costs | 54.9m | |
| Operating profit (EBIT) | −45.7m | |
| Net financial items | 547k | |
| Profit for the year | −38.5m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 156.1m | |
| of which current assets | 115.6m | |
| Equity | 140.1m | |
| Total liabilities | 15.9m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.